MIBLood-EV: An Online Reporting Tool to Facilitate the Standardized Reporting of Preanalytical Variables and Quality Control of Plasma and Serum to Enhance Rigor and Reproducibility in Liquid Biopsy Research
Pre-analytical variability significantly impacts the reproducibility of liquid biopsy research, which is critical for precision medicine and biomedical research. This report highlights the challenges and variability in the pre-analytical processes of liquid biopsies, especially regarding extracellular vesicles (EVs), which are crucial for diagnostics in oncology. The MIBlood-EV initiative aims to standardize the reporting of pre-analytical variables and the quality control of plasma and serum samples to enhance reproducibility in EV research. By providing a comprehensive and flexible reporting framework, MIBlood-EV seeks to improve the reliability of EV studies and facilitate the development of evidence-based protocols, ultimately advancing the field of liquid biopsy research.
Authors
- Rienk Nieuwland (ORCID: https://orcid.org/0000-0002-5671-3400)
- Dakota Gustafson (ORCID: https://orcid.org/0000-0001-8374-6331)
- Fabrice Lucien (ORCID: https://orcid.org/0000-0001-6149-345X)
Institutions
- Mayo Clinic (US)
- University of Toronto (CA)
- Toronto General Hospital (CA)
- Amsterdam Neuroscience (NL)
- Toronto General Hospital Research Institute
- University of Amsterdam (NL)
Publication Details
- Journal
- Biopreservation and Biobanking
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1089/bio.2024.0083
- Citations
- 2
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 1.42